Biotest AG and AERES Biomedical Successfully Complete Engineering of the Antibody BT-062
26-Jan-2005 -
In a collaborative research effort AERES Biomedical, Ltd. and Biotest AG successfully completed the engineering of the monoclonal antibody BT-062.
The candidate is directed against a tumor-specific target expressed by multiple myeloma and is in development for this life-threatening tumour of the ...
Biotest
clinical trials
multiple myeloma
+3